Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Suspected sepsis: recognition, diagnosis and early management

NICE guideline
Reference number: NG51
Published: 13 July 2016
Last updated: 19 March 2024

Sepsis - the recognition, diagnosis and management of severe sepsis: equality impact assessment form - scoping

Sepsis - the recognition, diagnosis and management of severe sepsis: equality impact assessment form - scoping

Sepsis - the recognition, diagnosis and management of severe sepsis: equality impact assessment form - scoping
20 July 2015
(222.19 Kb 4 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 20 July 2015

Consultation comments and responses (PDF 1.46 MB)

Published:

13 July 2016
Equality impact assessment (PDF 271 KB)

Published:

13 July 2016
Committee member list (PDF 262 KB)

Published:

14 July 2016
Draft guideline (PDF 5.76 MB)

Published:

11 January 2016
Comments form (MSWord 38 KB)

Published:

11 January 2016
Short version of draft guideline (PDF 901 KB)

Published:

11 January 2016
Guideline appendix A - G (PDF 2 MB)

Published:

11 January 2016
Guideline appendix H (PDF 3.85 MB)

Published:

11 January 2016
Guideline appendix I - O (PDF 2.37 MB)

Published:

11 January 2016
Equality impact assessment Section 3 (PDF 202 KB)

Published:

13 April 2016
Equality impact assessment Section 4 (PDF 200 KB)

Published:

03 May 2016
Stakeholder list (PDF 42 KB)

Published:

08 January 2016
Economic plan (MSWord 32 KB)

Published:

25 November 2015
Review questions (MSWord 15 KB)

Published:

25 November 2015
Search strategies (MSWord 184 KB)

Published:

25 November 2015
Minutes 9 (PDF 102 KB)

Published:

12 December 2016
Minutes 10 (PDF 99 KB)

Published:

12 December 2016
Minutes 11 (PDF 112 KB)

Published:

12 December 2016
Minutes 12 (PDF 96 KB)

Published:

12 December 2016
The recognition, diagnosis and management of severe : scope comments table (PDF 467 KB)

Published:

03 November 2014
The recognition, diagnosis and management of severe : GDG8 minutes 29 April 2015 (PDF 94 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG7 minutes 28 April 2015 (PDF 266 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG6 minutes 4 March 2015 (PDF 271 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG5 minutes 16 January 2015 (PDF 105 KB)

Published:

13 July 2015
The recognition, diagnosis and management of severe : GDG4 minutes 2 December 2014 (PDF 108 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG3 minutes 21 October 2014 (PDF 109 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG2 minutes 5 September 2014 (PDF 95 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG1 minutes 11 July 2014 (PDF 113 KB)

Published:

06 February 2015
The recognition, diagnosis and management of severe : GDG members list (PDF 103 KB)

Published:

05 September 2014
The recognition, diagnosis and management of severe : equality impact assessment form - scoping (PDF 222 KB)

Published:

20 July 2015
The recognition, diagnosis and management of severe : final scope (PDF 211 KB)

Published:

24 September 2014
The recognition, diagnosis and management of severe : draft scope (PDF 188 KB)

Published:

04 April 2014
Stakeholder list (PDF 14 KB)

Published:

25 April 2014